Targeting minimal residual disease: a path to cure?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting minimal residual disease: a path to cure?

Published:2018-01-29 Issue:4 Volume:18 Page:255-263
ISSN:1474-175X
Container-title:Nature Reviews Cancer
language:en
Short-container-title:Nat Rev Cancer

Author:

Luskin Marlise R.,Murakami Mark A.,Manalis Scott R.,Weinstock David M.

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://www.nature.com/articles/nrc.2017.125.pdf

Reference131 articles.

1. Buchner, T. et al. Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm — combined prospective analysis by the German AML Intergroup. J. Clin. Oncol. 30, 3604–3610 (2012).

2. Terwilliger, T. & Abdul-Hay, M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 7, e577 (2017).

3. Armitage, J. O. The aggressive peripheral T-cell lymphomas: 2017. Am. J. Hematol. 92, 706–715 (2017).

4. Kahl, B. Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma. Semin. Hematol. 45, 90–94 (2008).

5. Scagliotti, G. V. et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J. Clin. Oncol. 26, 3543–3551 (2008).

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy for monitoring minimal residual disease in colorectal cancer: A promising approach with clinical implications;Clinical Surgical Oncology;2024-09

2. Tumor Cell Stemness and Stromal Cell Features Contribute to Oral Cancer Outcome Disparity in Black Americans;Cancers;2024-07-31

3. Purinergic Ca2+ Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma;Cancers;2024-06-30

4. Mutation and cell state compatibility is required and targetable in Ph+acute lymphoblastic leukemia minimal residual disease;2024-06-10

5. Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature;Journal of Gastrointestinal Oncology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3